Physician profile
Daniel C Walters
NPI 1659665461
$14,931.92
in general payments reported to CMS, 2019-2025
45 companies · $4,293 in 2025
The $4,293 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,605 · 2020: $173 · 2021: $349 · 2022: $1,643 · 2023: $3,869 · 2024: $3,000 · 2025: $4,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,127 · Travel and Lodging: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,127.33 |
| Travel and Lodging | $2,034.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $4,161.92 | 2019-2025 | Orsiro Mission, Biomonitor, Amvia Edge |
| Abbott Laboratories | $2,792.58 | 2019-2024 | Aveir, Jot Dx, Ensite |
| Aop Health US, LLC | $1,542.33 | 2025 | Rapiblyk |
| Shockwave Medical, INC | $748.19 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $465.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $420.54 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $407.07 | 2022-2023 | Optimizer |
| Medtronic, INC. | $343.69 | 2021-2024 | Corevalve Evolut R, Venaseal |
| Abiomed | $337.26 | 2023-2024 | Impella |
| Chiesi USA, INC. | $291.54 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.68 | 2022-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $235.19 | 2022-2025 | Amvuttra |
| Novo Nordisk INC | $234.99 | 2022-2025 | Wegovy, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $231.56 | 2019-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $228.43 | 2022-2025 | Verquvo, Capvaxive |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $156.94 | 2022-2025 | Assure Wcd |
| Boston Scientific Corporation | $152.50 | 2022-2024 | Watchman Access System |
| Pfizer INC. | $149.40 | 2022-2024 | |
| Medtronic Vascular, INC. | $143.93 | 2019 | |
| W. L. Gore & Associates, INC. | $138.57 | 2022 | |
| Terumo Medical Corporation | $125.71 | 2019 | |
| Scpharmaceuticals INC. | $122.34 | 2023-2025 | |
| Amgen INC. | $121.68 | 2022-2025 | Repatha, Repatha |
| Philips North America LLC | $115.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $115.85 | 2023-2025 | Wainua |
| Cardiva Medical, INC. | $87.43 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Actelion Pharmaceuticals US, INC. | $83.45 | 2024-2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $78.52 | 2022-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $74.94 | 2022-2024 | Xarelto |
| Cardiovascular Systems INC. | $67.63 | 2022 | |
| Sanofi-Aventis U.S. LLC | $64.40 | 2022-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $48.72 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $47.77 | 2025 | Nexletol |
| Celgene Corporation | $46.75 | 2023 | Camzyos |
| Altathera Pharmaceuticals LLC | $44.82 | 2024-2025 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals, LTD. | $42.24 | 2023 | Arcalyst |
| Bridgebio Pharma, INC. | $32.20 | 2025 | Attruby |
| Corindus INC. | $30.65 | 2019 | |
| Cardiofocus, INC. | $30.45 | 2023 | Heartlight System |
| Atricure, INC. | $29.25 | 2024-2025 | Atriclip Laa Exclusion System |
| Cleerly, INC. | $27.82 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Csl Behring | $22.66 | 2022 | |
| Azurity Pharmaceuticals, INC. | $22.06 | 2023 | Edarbi |
| Tactile Systems Technology INC | $13.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.